Tianjin Ringpu Bio Tech (300119 SHE) stock market data APIs

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products. The company provides anthelmintics, pet vaccines, ear canal treatment drugs, anesthetic analgesics, antibiotics, antivirals, various internal medicine drugs, as well as disinfectant products, including compound potassium peroxymonosulphate, deciquam solution, and glutaral solution, API products, herbal medicines, and cleaning agents for poultry, waterfowl, livestock, ruminant, and companion animals. The company also provides disease diagnosis and testing services, consisting of animal disease diagnosis and testing, animal-derives food testing, and feed and pharmaceutical analysis testing; veterinary drug evaluation services comprising preclinical safety evaluation and clinical evaluation services for universities, research institutes, enterprises, and other entities; and socialized veterinary services, such as monitoring, testing, immunizing, quarantine, and investigating epidemiological surveys related to animal diseases to local governments. The company was founded in 1998 and is headquartered in Tianjin, China.